Covid-19 vaccines are on the way for younger children but at a different dose than teens and adults get. Here's what you need to know.
It's now discussing these findings with the US Food and Drug Administration, and Dr. Scott Gottlieb, a former FDA commissioner who is also on the board of Pfizer who may not have direct knowledge but who certainly has the basis to make an informed guess, says kids 5 and older could be getting Covid-19 shots by the end of October.But the vaccines these younger kids get will almost certainly be different than the shots teens and adults have been getting, at least in terms of the dose.
"If you look at the number of cases, the percentage of cases in the United States over the last couple of weeks, it's been closing in on 30% of the new cases have happened in children under 18. Children under 18 only make up about 20% of the population, so we're actually now having a disproportionate percentage of cases in children," he noted.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: NI records four Covid-linked deaths, 1,060 casesThe total number of deaths linked to coronavirus in NI since the start of the pandemic is 2,517.
Read more »
Students on cusp of COVID-19 vaccine age requirement wait patiently as 12th birthday approachesWhile medical experts say there is little that can be done for those soon-to-be 12-year-olds until the vaccines are approved for younger people, they say there are some tips that schools and families can take to ensure that each child is safe this year.
Read more »
2nd dose of J&J COVID-19 vaccine results in stronger protection, company saysThe new data, announced in a press release, adds to a growing body of evidence suggesting that booster shots could enhance vaccine protection against breakthrough infections -- though experts agree all three vaccines are still doing their job to protect against more serious illness. Compared to the Pfizer and Moderna vaccines, Johnson & Johnson's single-shot vaccine always had slightly lower efficacy. Peak efficacy from the two-shot Pfizer and Moderna vaccines was 95% and 94%, respectively, against symptomatic illness.
Read more »
India to target children for COVID-19 vaccine from Oct -sourcesAll Indian children aged 12 or older will become eligible for COVID-19 vaccinations from next month, when drug maker Cadila Healthcare launches its ZyCoV-D product, two sources with direct knowledge of the matter told Reuters.
Read more »